Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.10.0.1
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2018
Dec. 31, 2017
Current assets:    
Cash $ 67,622 $ 90,173
Accounts receivable 10,073
Prepaid expenses and other current assets 21,000 21,000
Total current assets 98,695 111,173
Property Plant and Equipment, net 8,754 1,064
Patents, net 4,176,545 4,500,000
Total assets 4,283,994 4,612,237
Current Liabilities    
Accounts payable and accrued expenses 3,069,985 2,714,041
Short term advances 20,323
Notes payable, net of discounts of $1,355,554 as of June 30, 2018 and $2,624,984 as of December 31, 2017 5,863,469 4,461,160
Notes payable - related parties 270,000 270,000
Derivative liability 3,119,924 5,939,600
Current portion of long term loan 4,221
Total current liabilities 12,323,378 13,409,345
Series C preferred stock liability, net of discounts of $115,596 at June 30, 2018 and $101,808 as of December 31, 2017 921,904 598,192
Acquisition payable 155,000 155,000
Total liabilities 13,400,282 14,162,537
COMMITMENTS AND CONTINGENCIES
Shareholders' deficit    
Super AA super voting preferred stock, $0.001 par value; 1,000,000 authorized and 5,000 and 5,000 issued and outstanding at June 30, 2018 and December 31, 2017 5 5
Series B convertible preferred stock, $0.0001 par value; 50,000 shares authorized, 1,350 and 0 issued and outstanding at June 30, 2018 and December 31, 2017 1
Common stock, $0.0001 par value; 500,000,000 shares authorized; 356,268,939 and 316,951,712 shares issued and outstanding as of June 30, 2018 and December 31, 2017 35,625 31,692
Additional paid-in capital 21,903,851 19,604,016
Stock subscriptions (1,570) (1,570)
Accumulated deficit (31,054,200) (29,184,443)
Total shareholders' deficit (9,116,288) (9,550,300)
Total liabilities and shareholders' deficit $ 4,283,994 $ 4,612,237